Showing results (181-190 of 229) with videos related to
Sort By:
Pageof 23
JAMA Oncology|May 27, 2016
Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During PregnancyChelsea C Pinnix, Eleanor M Osborne, Dai Chihara, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2021
Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell LymphomaPreetesh Jain, Shuangtao Zhao, Hun Ju Lee, et al.The New England Journal of Medicine|May 30, 2019
Ibrutinib and Venetoclax for First-Line Treatment of CLLNitin Jain, Michael Keating, Philip Thompson, et al.Blood Advances|October 14, 2022
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemiaWarren B Fingrut, Boglarka Gyurkocza, Jessica Flynn, et al.Blood|March 7, 2014
Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistanceRodrigo Jacamo, Ye Chen, Zhiqiang Wang, et al.Blood|February 22, 2003
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileAdrian Wiestner, Andreas Rosenwald, Todd S Barry, et al.Leukemia|April 28, 2019
CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activityFuliang Chu, Haiyan S Li, Xindong Liu, et al.Genome Biology|May 30, 2020
CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing dataLiqing Tian, Yongjin Li, Michael N Edmonson, et al.Blood Advances|June 15, 2025
A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphomaNeha Akkad, Lei Feng, Jason R Westin, et al.Blood|March 16, 2025
Blunted CD40-responsive enhancer activation in CREBBP-mutant lymphomas can be restored by enforced CD4 T-cell engagementHaopeng Yang, Wenchao Zhang, Vida Ravanmehr, et al.Pageof 23